Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Sep 26, 2023
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Reata Pharmaceuticals Inc
| -132.88K |
—
|
—
| -100.00% |
0
|
Sep 26
| |||||||
Reata Pharmaceuticals Inc
| 84.22K |
—
|
—
| +220.13% | 122.48K |
Jul 6
| |||||||
Reata Pharmaceuticals Inc
|
0
|
$85.46 | -$6,409,472.75 |
—
| 36.16K |
Mar 1 - Mar 2
| |||||||
Reata Pharmaceuticals Inc
| 47.02K |
—
|
—
|
∞
| 47.02K |
Jan 3
| |||||||
Reata Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
|
Jan 4
| |||||||
Reata Pharmaceuticals Inc
| -81.66K |
$175.01 | -$14,291,047.80 | -100.00% |
0
|
Nov 9 - Nov 10
|
Scheduled
| ||||||
Reata Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
|
Jan 2
| |||||||
Reata Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
|
Oct 14 - Nov 11
| |||||||
Reata Pharmaceuticals Inc
| -70.00K |
$86.61 | -$5,456,115.00 | -39.62% | 106.66K |
Sep 23 - Sep 27
| |||||||
Reata Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
|
Jan 2
| |||||||
Reata Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
|
Dec 12
| |||||||
Reata Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
|
Dec 6
| |||||||
Reata Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
|
Dec 7
| |||||||
Reata Pharmaceuticals Inc
| 179.82K |
$11.00 |
—
|
∞
| 179.82K |
Jun 1
| |||||||
Reata Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
| ||||||||
Reata Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
|
May 25
| |||||||
Reata Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
| ||||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||